ENIMMUNE CORPORATION
Update：2025/12/24
Industries
Main Industry
Biotechnology
Main Product/Service
At ENIMMUNE, our main business activity is to conduct clinical trials of new drugs, develop sales outlets, and collaborate with research-based pharmaceutical companies to facilitate the commercialization of new drugs. By forging an alliance within the eco
Founded Year
2014
Unified Business No.
54665910
Status
Active
Number of Employees
0
Total Paid-in
Capital
721,340,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2018)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Enimmune Corp. is a biologics research and marketing company jointly established by Adimmune Corporation and a venture capital firm. Upholding an idea that the pharmaceutical industry is a life-saving cause, we are actively developing new drugs and sales
